MELAFIND

Optical Diagnostic Device For Melanoma Detection

FDA Premarket Approval P090012 S008

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for changes to the test procedures for the hand held cart assembly; deployment of new software and installation workstations and an update for the hand held test method.

DeviceMELAFIND
Classification NameOptical Diagnostic Device For Melanoma Detection
Generic NameOptical Diagnostic Device For Melanoma Detection
ApplicantSTRATA SKIN SCIENCES, INC.
Date Received2014-04-29
Decision Date2015-01-26
PMAP090012
SupplementS008
Product CodeOYD
Advisory CommitteeGeneral & Plastic Surgery
Supplement Type135 Review Track For 30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address STRATA SKIN SCIENCES, INC. 100 Lakeside Dr Ste 100 horsham, PA 19044

Supplemental Filings

Supplement NumberDateSupplement Type
P090012Original Filing
S011 2015-06-11 Normal 180 Day Track
S010 2014-06-17 Normal 180 Day Track
S009 2014-04-29 30-day Notice
S008 2014-04-29 135 Review Track For 30-day Notice
S007 2014-04-29 135 Review Track For 30-day Notice
S006 2014-04-29 135 Review Track For 30-day Notice
S005 2014-04-29 135 Review Track For 30-day Notice
S004 2014-04-29 135 Review Track For 30-day Notice
S003 2014-02-12 Normal 180 Day Track No User Fee
S002 2012-08-13 Normal 180 Day Track No User Fee
S001 2011-11-01 Normal 180 Day Track No User Fee

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.